IBM Retirement Fund cut its position in AptarGroup Inc. (NYSE:ATR) by 1.7% during the second quarter, Holdings Channel reports. The fund owned 6,263 shares of the company’s stock after selling 108 shares during the period. IBM Retirement Fund’s holdings in AptarGroup were worth $496,000 as of its most recent filing with the SEC.
Several other institutional investors also recently modified their holdings of the company. C M Bidwell & Associates Ltd. boosted its position in shares of AptarGroup by 16.9% in the first quarter. C M Bidwell & Associates Ltd. now owns 1,555 shares of the company’s stock worth $122,000 after buying an additional 225 shares during the last quarter. Independent Portfolio Consultants Inc. boosted its position in shares of AptarGroup by 8.6% in the second quarter. Independent Portfolio Consultants Inc. now owns 2,020 shares of the company’s stock worth $160,000 after buying an additional 160 shares during the last quarter. Fiduciary Management Inc. WI bought a new position in shares of AptarGroup during the first quarter worth about $212,000. Magnetar Financial LLC bought a new position in shares of AptarGroup during the first quarter worth about $232,000. Finally, Rehmann Capital Advisory Group bought a new position in shares of AptarGroup during the first quarter worth about $238,000. 88.33% of the stock is owned by institutional investors and hedge funds.
Shares of AptarGroup Inc. (NYSE:ATR) traded down 0.84% on Friday, reaching $78.79. The company’s stock had a trading volume of 157,113 shares. AptarGroup Inc. has a 52-week low of $63.62 and a 52-week high of $81.50. The firm has a 50 day moving average of $77.63 and a 200 day moving average of $77.71. The company has a market cap of $4.96 billion, a PE ratio of 25.58 and a beta of 0.93.
AptarGroup (NYSE:ATR) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. AptarGroup had a net margin of 8.54% and a return on equity of 16.67%. The company earned $620 million during the quarter, compared to the consensus estimate of $621.52 million. During the same period in the previous year, the business earned $0.82 earnings per share. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. Analysts predict that AptarGroup Inc. will post $3.18 earnings per share for the current year.
A number of brokerages have recently issued reports on ATR. Robert W. Baird increased their target price on AptarGroup from $80.00 to $84.00 and gave the stock a “neutral” rating in a report on Friday, September 9th. BMO Capital Markets restated a “hold” rating on shares of AptarGroup in a research report on Friday, September 9th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $76.00.
In other AptarGroup news, Director King W. Harris sold 13,100 shares of the business’s stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $76.62, for a total transaction of $1,003,722.00. Following the completion of the transaction, the director now directly owns 195,509 shares in the company, valued at $14,979,899.58. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Salim Haffar sold 50,333 shares of the business’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $78.74, for a total transaction of $3,963,220.42. Following the transaction, the insider now owns 23,149 shares of the company’s stock, valued at $1,822,752.26. The disclosure for this sale can be found here. 5.50% of the stock is currently owned by insiders.
AptarGroup Company Profile
AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located in North America, Europe, Asia and South America.
Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup Inc. (NYSE:ATR).
Receive News & Ratings for AptarGroup Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup Inc. and related companies with MarketBeat.com's FREE daily email newsletter.